Loeb Partners Corp’s Quest Diagnostics DGX Stock Holding History

Loeb Partners Corp’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,500	Closed	-$291K	–	171
2018 Q4	$291K	Hold	3,500	–	–	0.14%	116
2018 Q3	$378K	Sell	3,500 -3,500	-50%	-$384K	0.14%	111
2018 Q2	$770K	Buy	7,000 +3,500	+100%	+$365K	0.19%	104
2018 Q1	$351K	Hold	3,500	–	–	0.15%	99
2017 Q4	$345K	Hold	3,500	–	–	0.1%	125
2017 Q3	$328K	Hold	3,500	–	–	0.1%	136
2017 Q2	$389K	Hold	3,500	–	–	0.11%	131
2017 Q1	$344K	Hold	3,500	–	–	0.1%	135
2016 Q4	$322K	Hold	3,500	–	–	0.11%	129
2016 Q3	$296K	Hold	3,500	–	–	0.11%	124
2016 Q2	$285K	Buy	+3,500	New	+$267K	0.09%	129

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Loeb Partners Corp's DGX Position: Q1 2019 in Review

Loeb Partners Corp sold out of Quest Diagnostics (DGX) in Q1 2019, closing a stake of 3,500 shares — an estimated $291K sold.

Loeb Partners Corp first reported a position in DGX in Q2 2016 and held it in 11 quarters. The position peaked at $770K in Q2 2018. 656 funds tracked by Wall St. Rank hold DGX as of Q1 2019.

Loeb Partners Corp reported no remaining Quest Diagnostics position as of Q1 2019 after selling out during the quarter.
Loeb Partners Corp sold 3,500 Quest Diagnostics shares in Q1 2019, an estimated $291K.
Loeb Partners Corp first reported a position in Quest Diagnostics in Q2 2016 and held it in 11 quarters.
Loeb Partners Corp's Quest Diagnostics position peaked at $770K in Q2 2018.
656 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2019.

Based on Loeb Partners Corp's 13F filing for Q1 2019, filed 14 May 2019.